After 3 weeks of pharmacological inhibition, liver nodules from treated Mdr2-deficient mice appeared to be smaller, with lower HCC content in each nodule compared with untreated Mdr2-deficient mice, although there were a similar number of nodules in each group. This evidence concerns the gene ABCB4 and hepatocellular carcinoma.